newsfilter
← Latest News
Business Wire·

Ivonescimab Data Sets across Multiple Tumor Types to Be Featured at ESMO 2026

Highlights Include Phase II Data Supporting Clinical Development Expansion for Ivonescimab Summit Therapeutics Inc. (NASDAQ:SMMT) today announced that ivonescimab data will be featured in numerous presentations at